Age, sex, hypertension, smoking, hypercholesterolemia, diabetes mellitus, peripheral vascular disease, and chronic obstructive pulmonary disease as well as the use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, statins, β-blockers, and calcium channel blockers differed significantly between the two groups. This evidence concerns the gene ACE and chronic obstructive pulmonary disease.